AMYRIS BIOTECHNOLOGIES

Basic Information

AMYRIS BIOTECHNOLOGIES
412 B KAINS AVE
ALBANY, CA, 94706 0126

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Economical production of artemisinin precursors

    Amount: $597,202.00

    DESCRIPTION (provided by applicant): In many regions of the world, strains of Plasmodium have emerged that are resistant to the current arsenal of antimalarial therapeutics. Artemisinins, terpenoid c ...

    SBIR Phase I 2004 Department of Health and Human Services
  2. Heterologous Production of Eleutherobin Precursors

    Amount: $99,495.00

    DESCRIPTION (provided by applicant): Terpenoids are a diverse class of natural compounds with equally diverse and potent bioactivities. Because the practical use of terpenoids hinges on the ability to ...

    STTR Phase I 2004 Department of Health and Human Services
  3. Next-Generation Scalable Parallel Circuit Simulation for General Purpose Parallel Architectures

    Amount: $100,000.00

    Circuit simulation is a critical bottleneck in design of complex VLSI chips. Even though clock speed and processing power of general purpose workstations are improving constantly, increases in size an ...

    SBIR Phase I 1995 Defense Advanced Research Projects Agency Department of Defense

Agency Micro-sites

US Flag An Official Website of the United States Government